Nanoparticulate systems for the delivery of antisense oligonucleotides

被引:152
作者
Lambert, G [1 ]
Fattal, E [1 ]
Couvreur, P [1 ]
机构
[1] Fac Pharm Chatenay Malabry, URA CNRS 8612, Lab Phys Chim Pharmacotech & Biopharm, F-92296 Chatenay Malabry, France
关键词
nanoparticles; nanocapsules; nanospheres; oligonucleotide; antisense;
D O I
10.1016/S0169-409X(00)00116-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antisense oligonucleotides are molecules that are able to inhibit gene expression being therefore potentially active for the treatment of viral infections or cancer, However, because of their poor stability in biological medium and their weak intracellular penetration, colloidal drugs carriers such as nanoparticles were developed for the delivery of oligonucleotides (ODN). ODN associated to nanoparticles were shown to be protected against degradation and to penetrate more easily into different types of cells. As a consequence, nanoparticles were shown to improve the efficiency of ODNs for the inhibition of the proliferation of cells expressing the point mutated Ha-ras gene. In vivo, polyalkylcyanoacrylate (PACA) nanoparticles were able to efficiently distribute the ODNs to the liver whereas the alginate nanosponges could concentrate the ODNs in the lungs. Finally, ODN loaded to PACA nanoparticles were able to improve in mice, the treatment of RAS cells expressing the point mutated Ha-ras gene, (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 112
页数:14
相关论文
共 73 条
[1]   PREPARATION OF AQUEOUS POLYMERIC NANODISPERSIONS BY A REVERSIBLE SALTING-OUT PROCESS - INFLUENCE OF PROCESS PARAMETERS ON PARTICLE-SIZE [J].
ALLEMANN, E ;
GURNY, R ;
DOELKER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :247-253
[2]   Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides [J].
Aynié, I ;
Vauthier, C ;
Chacun, H ;
Fattal, E ;
Couvreur, P .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (03) :301-312
[3]   Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier [J].
Aynie, I ;
Vauthier, C ;
Foulquier, M ;
Malvy, C ;
Fattal, E ;
Couvreur, P .
ANALYTICAL BIOCHEMISTRY, 1996, 240 (02) :202-209
[4]   LIPOSOMES WITH PROLONGED BLOOD-CIRCULATION AND SELECTIVE LOCALIZATION IN KLEBSIELLA-PNEUMONIAE INFECTED LUNG-TISSUE [J].
BAKKERWOUDENBERG, IAJM ;
LOKERSE, AF ;
TENKATE, MT ;
MOUTON, JW ;
WOODLE, MC ;
STORM, G .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01) :164-171
[5]  
BALLAND O, 1996, STRATEGIES OLIGONUCL, P1431
[6]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[7]   2ND STRUCTURAL MOTIF FOR RECOGNITION OF DNA BY OLIGONUCLEOTIDE-DIRECTED TRIPLE-HELIX FORMATION [J].
BEAL, PA ;
DERVAN, PB .
SCIENCE, 1991, 251 (4999) :1360-1363
[8]  
Been MD, 1993, NUCLEASES, P407
[9]   Antisense oligonucleotides: Is the glass half full or half empty? [J].
Bennett, CF .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (01) :9-19
[10]  
BIRRENBACH G, 1976, J PHARM SCI, V65, P1763, DOI 10.1002/jps.2600651217